Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRS, HIPEC, and IP Chemotherapy in Gastric Cancer with Peritoneal Metastasis
NCT02995850Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Feb 2017
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of paclitaxel oral solution, cisplatin and tegafur in gastric cancer (GC) and peritoneal metastasis (PM), sponsored by Yonsei University. Started Feb 2017; status: completed.
02
Drugs
paclitaxel oral solutioncisplatintegafur
03
Conditions
gastric cancer (GC)peritoneal metastasis (PM)
Beyond the preview
Go deeper on NCT02995850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995850.